Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN319436 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Insulin-Like Growth Factor 1 Receptor (IGF1R) (Chain alpha) antibody
- Antibody type
- Monoclonal
- Description
- Purified IgG prepared by affinity chromatography on Protein G from tissue culture supernatant
- Reactivity
- Human
- Host
- Mouse
- Epitope
- Chain alpha
- Isotype
- IgG
- Antibody clone number
- 1H7
- Vial size
- 25 μg
- Storage
- Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references IGF1-R inhibition and liposomal doxorubicin: Progress in preclinical evaluation for the treatment of adrenocortical carcinoma.
Liposomal doxorubicin-based treatment in a preclinical model of adrenocortical carcinoma.
Anti insulin-like growth factor I receptor immunoliposomes: a single formulation combining two anticancer treatments with enhanced therapeutic efficiency.
Beuschlein F, Jakoby J, Mentz S, Zambetti G, Jung S, Reincke M, Süss R, Hantel C
Molecular and cellular endocrinology 2016 Jun 15;428:82-8
Molecular and cellular endocrinology 2016 Jun 15;428:82-8
Liposomal doxorubicin-based treatment in a preclinical model of adrenocortical carcinoma.
Hantel C, Lewrick F, Reincke M, Süss R, Beuschlein F
The Journal of endocrinology 2012 May;213(2):155-61
The Journal of endocrinology 2012 May;213(2):155-61
Anti insulin-like growth factor I receptor immunoliposomes: a single formulation combining two anticancer treatments with enhanced therapeutic efficiency.
Hantel C, Lewrick F, Schneider S, Zwermann O, Perren A, Reincke M, Süss R, Beuschlein F
The Journal of clinical endocrinology and metabolism 2010 Feb;95(2):943-52
The Journal of clinical endocrinology and metabolism 2010 Feb;95(2):943-52
No comments: Submit comment
No validations: Submit validation data